Reviewing the most recent target from each covering firm yields roughly 18 individual 12-month price targets, ranging from a low of about $100 to a high of about $162. The overall mean of all of these targets is near $134 — only a couple of percentage points above the share price. Because that fails the 10% minimum-distance test, the central target is instead calculated from the targets that sit above the current price. Those 11 targets — including $162 at UBS, $158 at Wolfe Research, $149 at Oppenheimer, $148 at StoneX, $146 at Bank of America, and $145 at both Wells Fargo and Raymond James — average roughly $146, rounded to a clean $145.
The spread between the $100 low (Seaport Global, which downgraded the shares to Sell) and the $162 high (UBS) reflects genuine disagreement about the housing cycle. Neutral-rated firms such as RBC Capital ($110), Barclays ($109), Citi ($122), Morgan Stanley ($128), and Melius Research ($132) see limited upside, while Buy-rated firms see resilience. After a third-quarter miss, most firms trimmed targets but kept ratings: Evercore ISI moved to $143, Goldman Sachs nudged its target up to $140, and Truist sits at $136. The overall stance is best described as a Moderate Buy with a wide valuation debate. I also checked this using Tickeron’s AI Screener to see how PHM compares to others in the industry.
At about $131, the stock needs to rise roughly 11% to reach $145 — a substantial but not extreme move. The near-term earnings picture is challenging: third-quarter EPS of $2.53 missed the $2.63 consensus, and revenue of $3.97 billion fell 9.8% year over year and missed estimates. Home closings fell 9% to 6,876 units, net new orders slipped 6% to 6,208, and the average sales price dipped 1% to $561,000. Yet gross margin held at a resilient 24.8%, and backlog grew 4% to 10,298 homes. At roughly 12 times trailing earnings — below many large public builders — the valuation is not demanding, but the earnings denominator is under pressure.
PHM's balance sheet is a defining strength: about $1.4 billion in cash, a debt-to-capital ratio near 12%, and $350 million of share repurchases in the quarter. The company's tilt toward higher-margin move-up and active-adult communities (Del Webb) helps protect profitability even as volumes fall, and its mortgage arm captures a large share of its buyers. A structural undersupply of U.S. housing, eventual relief in mortgage rates, and continued capital returns are the core bullish arguments that underpin the above-price targets.
Mortgage rates above 7% and stretched affordability are pushing buyers to the sidelines, and the gap between orders and closings points to a lower volume base in coming quarters. Rising incentives and land costs threaten margin compression, while analysts have been steadily lowering targets for months. Additional headwinds include elevated resale and new-home inventory, a more competitive selling environment, and broader macroeconomic uncertainty — including reported scrutiny of homebuilder practices — that could compress valuation multiples.
The stock's 52-week range spans roughly $107 to $144.50. After touching a low near $109 in mid-October, shares have rallied back to about $131, reclaiming both the 50-day (near $120) and 200-day (near $123) moving averages. That places the $144–$145 zone — the prior high and the target itself — as the key resistance level to clear, while support sits near $120–$125 and then around $109. From what I see, the recent recovery in moving averages is worth watching closely.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms do not publish uniform assumptions. The most important catalysts are the next earnings report, net new orders relative to closings, the spring selling season, any shift in mortgage rates or Federal Reserve policy, and the direction of analyst revisions. Buyback activity and margin commentary on the earnings call will also shape whether the average analyst price target — and the stock — can climb toward $145. I’m watching this closely as order trends develop.
In my view, Tickeron’s AI Daily Buy/Sell Signals provide a useful layer when following names like PHM. The tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use it to surface new opportunities, keep an eye on existing positions, and spot changing trends more efficiently than scanning charts manually. These signals can complement your own research when tracking PulteGroup.
The $145 target is the average of the analyst price targets that sit above the current price, not an official consensus. It requires roughly an 11% gain from about $131. The bull case rests on a clean balance sheet, buybacks, and a resilient margin mix, while the bear case points to high mortgage rates, softening orders, and continued estimate cuts — reflected in a very wide $100-to-$162 target range. Whether PHM can reach $145 will depend on whether order trends stabilize and mortgage rates ease; it is a genuine debate, not a settled outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
PHM saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 67 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 72%.
The 10-day RSI Indicator for PHM moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 20 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 48%.
The Moving Average Convergence Divergence Histogram (MACD) for PHM turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 30 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
PHM broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
PHM moved above its 50-day moving average on October 23, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PHM crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +5.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHM advanced for three days, in 212 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 210 of 287 cases where PHM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 27 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PHM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 57 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.939) is normal, around the industry mean (1.910). P/E Ratio (13.437) is within average values for comparable stocks, (10.592). Projected Growth (PEG Ratio) (0.995) is also within normal values, averaging (1.217). Dividend Yield (0.008) settles around the average of (0.019) among similar stocks. P/S Ratio (1.393) is also within normal values, averaging (24.205).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the homebuilding business
Industry Homebuilding